Pharmacological inhibition of Dock5 prevents osteolysis by affecting osteoclast podosome organization while preserving bone formation-Reference-Cited by-同舟云学术

Pharmacological inhibition of Dock5 prevents osteolysis by affecting osteoclast podosome organization while preserving bone formation

Published:2015-02-03 Issue:1 Volume:6 Page:
ISSN:2041-1723
Container-title:Nature Communications
language:en
Short-container-title:Nat Commun

Author:

Vives Virginie,Cres Gaëlle,Richard Christian,Busson Muriel,Ferrandez Yann,Planson Anne-Gaelle,Zeghouf Mahel,Cherfils Jacqueline,Malaval Luc,Blangy Anne

Publisher

Springer Science and Business Media LLC

Subject

General Physics and Astronomy,General Biochemistry, Genetics and Molecular Biology,General Chemistry

Link

http://www.nature.com/articles/ncomms7218.pdf

Reference27 articles.

1. Seeman, E. Invited Review: Pathogenesis of osteoporosis. J. Appl. Physiol. 95, 2142–2151 (2003).

2. Baron, R., Ferrari, S. & Russell, R. G. Denosumab and bisphosphonates: different mechanisms of action and effects. Bone 48, 677–692 (2011).

3. Black, D. M. et al. The effects of parathyroid hormone and alendronate alone or in combination in postmenopausal osteoporosis. New Engl. J. Med. 349, 1207–1215 (2003).

4. Gedmintas, L., Solomon, D. H. & Kim, S. C. Bisphosphonates and risk of subtrochanteric, femoral shaft, and atypical femur fracture: a systematic review and meta-analysis. J. Bone. Miner. Res. 28, 1729–1737 (2013).

5. Yamashita, J. & McCauley, L. K. Antiresorptives and osteonecrosis of the jaw. J. Evid. Based Dent. Pract. 12, 233–247 (2012).

Cited by 55 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Liraglutide Promotes Diabetic Wound Healing via Myo1c/Dock5;Advanced Science;2024-08-19

2. Jiangu formula: A novel osteoclast-osteoblast coupling agent for effective osteoporosis treatment;Phytomedicine;2024-06

3. Roles Played by DOCK11, a Guanine Nucleotide Exchange Factor, in HBV Entry and Persistence in Hepatocytes;Viruses;2024-05-08

4. Bone resorption by osteoclasts involves fine tuning of RHOA activity by its microtubule-associated exchange factor GEF-H1;Frontiers in Physiology;2024-01-19

5. Dock5 Deficiency Promotes Proteinuric Kidney Diseases via Modulating Podocyte Lipid Metabolism;Advanced Science;2023-12-31